Boulland ML - Search Results

1

Expression of p53 protein in T- and natural killer-cell lymphomas is associated with some clinicopathologic entities but rarely related to p53 mutations.

Petit B, Leroy K, Kanavaros P, Boulland ML, Druet-Cabanac M, Haioun C, Bordessoule D, Gaulard P. Petit B, et al. Among authors: boulland ml. Hum Pathol. 2001 Feb;32(2):196-204. doi: 10.1053/hupa.2001.21569. Hum Pathol. 2001. PMID: 11230707

2

Langerhans' cell histiocytosis. Definitive diagnosis with the use of monoclonal antibody O10 on routinely paraffin-embedded samples.

Emile JF, Wechsler J, Brousse N, Boulland ML, Cologon R, Fraitag S, Voisin MC, Gaulard P, Boumsell L, Zafrani ES. Emile JF, et al. Among authors: boulland ml. Am J Surg Pathol. 1995 Jun;19(6):636-41. doi: 10.1097/00000478-199506000-00003. Am J Surg Pathol. 1995. PMID: 7755150

3

CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas.

Emile JF, Boulland ML, Haioun C, Kanavaros P, Petrella T, Delfau-Larue MH, Bensussan A, Farcet JP, Gaulard P. Emile JF, et al. Among authors: boulland ml. Blood. 1996 Feb 15;87(4):1466-73. Blood. 1996. PMID: 8608237 Free article.

4

Interleukin-7 receptor expression in cutaneous T-cell lymphomas.

Bagot M, Charue D, Boulland ML, Gaulard P, Revuz J, Schmitt C, Wechsler J. Bagot M, et al. Among authors: boulland ml. Br J Dermatol. 1996 Oct;135(4):572-5. Br J Dermatol. 1996. PMID: 8915148

5

Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.

Boulland ML, Kanavaros P, Wechsler J, Casiraghi O, Gaulard P. Boulland ML, et al. J Pathol. 1997 Dec;183(4):432-9. doi: 10.1002/(SICI)1096-9896(199712)183:4<432::AID-PATH942>3.0.CO;2-4. J Pathol. 1997. PMID: 9496260

6

Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.

Boulland ML, Meignin V, Leroy-Viard K, Copie-Bergman C, Brière J, Touitou R, Kanavaros P, Gaulard P. Boulland ML, et al. Am J Pathol. 1998 Oct;153(4):1229-37. doi: 10.1016/S0002-9440(10)65667-2. Am J Pathol. 1998. PMID: 9777954 Free PMC article.

7

Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.

Kanavaros P, Vlychou M, Stefanaki K, Rontogianni D, Gaulard P, Pantelidaki E, Zois M, Darivianaki K, Georgoulias V, Boulland ML, Gorgoulis V, Kittas C. Kanavaros P, et al. Among authors: boulland ml. Anticancer Res. 1999 Mar-Apr;19(2A):1209-16. Anticancer Res. 1999. PMID: 10368677

8

Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.

Boulland ML, Wechsler J, Bagot M, Pulford K, Kanavaros P, Gaulard P. Boulland ML, et al. Histopathology. 2000 Feb;36(2):136-44. doi: 10.1046/j.1365-2559.2000.00799.x. Histopathology. 2000. PMID: 10672058

9

Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.

Kanavaros P, Boulland ML, Petit B, Arnulf B, Gaulard P. Kanavaros P, et al. Among authors: boulland ml. Leuk Lymphoma. 2000 Jul;38(3-4):317-26. doi: 10.3109/10428190009087022. Leuk Lymphoma. 2000. PMID: 10830738 Review.

10

MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas.

Copie-Bergman C, Plonquet A, Alonso MA, Boulland ML, Marquet J, Divine M, Möller P, Leroy K, Gaulard P. Copie-Bergman C, et al. Among authors: boulland ml. Mod Pathol. 2002 Nov;15(11):1172-80. doi: 10.1097/01.MP.0000032534.81894.B3. Mod Pathol. 2002. PMID: 12429796

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters